Inovio Pharma (INO) Data Reported Was Positive, "Terrific Vaccine in a World of Unknowns" - Stifel
Tweet Send to a Friend
Stifel maintains Buy on Inovio Pharmaceuticals (NASDAQ: INO) price target of $11.00.Analyst Dr. Tom Shrader comments on two positives from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
